A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Clinical trial NCT06474455 · RECRUITING
Trial details
- NCT number
- NCT06474455
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-02
- Primary completion
- 2029-06-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.